These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 30944133

  • 1. Efficacy and safety of Chou-Ling-Dan granules in the treatment of seasonal influenza via combining Western and traditional Chinese medicine: protocol for a multicentre, randomised controlled clinical trial.
    He J, Li Z, Huang W, Guan W, Ma H, Yang ZF, Wang X.
    BMJ Open; 2019 Apr 02; 9(4):e024800. PubMed ID: 30944133
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and safety of Ban-Lan-Gen granules in the treatment of seasonal influenza: study protocol for a randomized controlled trial.
    Li ZT, Li L, Chen TT, Li CY, Wang DQ, Yang ZF, Zhong NS.
    Trials; 2015 Mar 28; 16():126. PubMed ID: 25873046
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of Traditional Chinese Medicine, Maxingshigan-Weijing in the management of COVID-19 patients with severe acute respiratory syndrome: A structured summary of a study protocol for a randomized controlled trial.
    Zeng C, Yuan Z, Pan X, Zhang J, Zhu J, Zhou F, Shan Z, Yuan Y, Ye R, Cheng J.
    Trials; 2020 Dec 23; 21(1):1029. PubMed ID: 33357239
    [Abstract] [Full Text] [Related]

  • 4. [Efficacy and safety of Kangbingdu granules in the treatment of influenza: a randomized, double-blind, double-dummy, positive-drug parallel control multicenter clinical trial].
    Nong Y, Lin JT, Sun XW, Wang J, Ma X, Liu XP, Wang HQ, Zha RT, Shen DP, Jiang SJ, Luo SK, Zhao Q, Meng L, Wang WP, Fang J, Han LM, Lu GB, Zhang W, Li GF, Wang H, Zhao ZY, Zhou W, Wei BL, Yuan YD, Peng LP, Lu XL, Pang GF, Li FH, Li L, Zhen H.
    Zhonghua Yi Xue Za Zhi; 2021 Jan 19; 101(3):205-211. PubMed ID: 33370867
    [Abstract] [Full Text] [Related]

  • 5. Effectiveness and safety of Chinese herbal medicine xuanbi antong granules for the treatment of borderline coronary lesions: study protocol for a randomised, double-blinded, placebo-controlled, multicentre clinical trial.
    Huang M, Chen G, Guan Q, Liu C, Zhao Q, Li J, Yao K, Zhang Z, He H, Li Y, Lin F, He X, Liu Y, Xiong XJ, Zhang Y, Han M, Wang J.
    BMJ Open; 2019 Aug 08; 9(8):e024968. PubMed ID: 31399446
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of efficacy and safety of Qiangzhu-qinggan formula as an adjunctive therapy in adult patients with severe influenza: study protocol for a randomized parallel placebo-controlled double-blind multicenter trial.
    Qiu L, Wu XW, Zhang SY, Yang M, Zhang SX, Fu JY, Li C, Zhang ZJ, Zheng PY, Lu ZH.
    Trials; 2021 Dec 27; 22(1):955. PubMed ID: 34961550
    [Abstract] [Full Text] [Related]

  • 7. Traditional Chinese medicine in the treatment of idiopathic pulmonary fibrosis based on syndrome differentiation: Study protocol of an exploratory trial.
    Yu XQ, Yang SG, Xie Y, Li JS.
    J Integr Med; 2020 Mar 27; 18(2):163-168. PubMed ID: 31928920
    [Abstract] [Full Text] [Related]

  • 8. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A, Chua JV, Talwani R, Bentzen SM, Baddley J.
    Trials; 2020 Oct 28; 21(1):897. PubMed ID: 33115543
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Efficacy and safety of Anluohuaxian in the treatment of patients with severe Coronavirus disease 2019- a multicenter, open label, randomized controlled study: a structured summary of a study protocol for a randomised controlled trial.
    Zhang C, Li J, Wu Z, Wang H, Que C, Zhao H, Wang G.
    Trials; 2020 Jun 08; 21(1):495. PubMed ID: 32513299
    [Abstract] [Full Text] [Related]

  • 17. Exploration of the utility of different doses of Qingfei Dayuan granules: a multicenter, randomized, double-blind, placebo-controlled trial.
    Zhu X, Li W, Yang Y, Li H, Yang M, Zhang J, Li X, Yan G, Wu X, Zhao W, Cui M, Yang X, Hu X, Huang J, Ba Y.
    Aging (Albany NY); 2024 Feb 26; 16(5):4503-4517. PubMed ID: 38412322
    [Abstract] [Full Text] [Related]

  • 18. Yinang formulation versus placebo granules as a treatment for chronic kidney disease stages III-IV in patients with autosomal dominant polycystic kidney disease: study protocol for a double-blind placebo-controlled randomized clinical trial.
    Gan J, Wu Y, Gong X, Ma Y, Yu S, Gao J.
    Trials; 2019 Aug 07; 20(1):481. PubMed ID: 31391092
    [Abstract] [Full Text] [Related]

  • 19. Clinical and virological outcomes with baloxavir compared with oseltamivir in pediatric patients aged 6 to < 12 years with influenza: an open-label, randomized, active-controlled trial protocol.
    Ishiguro N, Morioka I, Nakano T, Furukawa M, Tanaka S, Kinoshita M, Manabe A.
    BMC Infect Dis; 2021 Aug 09; 21(1):777. PubMed ID: 34372769
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.